Show results for
Refine by
Drug Development Process Suppliers Serving Thailand
35 companies found
based inLake Villa, ILLINOIS (USA)
Unified Information Devices (UID) is a leading provider of radio-frequency identification (RFID) solutions that empower researchers to generate higher quality data faster, accurately and consistently. UID Identification Solutions combines advanced ...
based inYongin, SOUTH KOREA
Bilix is established based on the world’s first PEGylated bilirubin platform technology to produce numerous “First in Class” in anti-inflammatory and “Best in Class” in cancer therapy drugs in addition to achieving other business platform such as ...
based inPrinceton, NEW JERSEY (USA)
The drug discovery and development process is long and expensive with more failures than successes. At Certara, we anticipate and address your critical drug discovery and development risks and decisions using biosimulation, technology and services. ...
based inPasadena, VIRGINIA (USA)
Parsons, an engineering, construction, technical, and management services firm with revenues of $3 billion in 2013, is 100% owned by the Employee Stock Ownership Trust. Parsons is a leader in many diversified markets with a focus on transportation, ...
An integrated approach for project success Parsons supports its life sciences customers with commissioning, qualifications, and validation needs by routinely performing validation planning for biotechnology, active pharmaceutical ingredients, dosage ...
based inNanjing, CHINA
Founded in July 2015, Triastek is dedicated to the mission of 'revolutionizing the pharmaceutical industry, unlocking the next generation of medicine and benefitting patients worldwide.' We have created the Melt Extrusion Deposition (MED) 3D ...
Furthermore, the precise delivery mechanisms are coupled with robust image tracking technology, optimizing research and development efficiency and hence, expediting the drug development ...
based inCambridge, ONTARIO (CANADA)
Advanced Electrophoresis Solutions Ltd. (AES) was founded in 2010. The Company is dedicated in providing cutting-edge instrumentations, ampholytes, and supplies in the iCIEF field. The Company now has become a unique total solution provider for ...
With our ISO:9001 certification, AES is proud to offer a comprehensive range of critical consumables, including proprietary cartridges, ampholytes, pI markers, electrolytes, and general solutions and consumables. In particular, we are ...
based inMenlo Park, CALIFORNIA (USA)
Strateos Software, a suite of products to automate and centralize your laboratory. Strateos is a pioneer in the development of remote access laboratories and lab control software for life science discovery. Our mission is to create new knowledge ...
Strateos offers a wide range of off the shelf drug discovery assays and supports custom development of biochemical, biophysical and cell based assays in drug discovery, using both industry-standard and innovative technologies to support drug ...
based inOceanside, CALIFORNIA (USA)
Eidogen-Sertanty is dedicated to improving health, medicine, and general well-being. For the last 20-years, Eidogen-Sertanty has helped to expedite the discovery and development of many new, safer medicines through collaborative project team ...
based inSeattle, WASHINGTON (USA)
Nexelis is your partner for assay and biomarker development, advanced bioanalytical and laboratory testing, and translational immunology. As the leading specialty laboratory, we have unrivaled expertise in immunology, specifically in the areas of ...
Accelerating Drug Development Process at Scale: Nexelis, a Q² Solutions Company, utilizes automated systems for high throughput through our investment in robotics to support our scientists, who ...
based inWaltham, MASSACHUSETTS (USA)
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Precision NanoSystems is a global leader in technologies, solutions and services for the development of non-viral delivery of genomic medicines, including mRNA vaccines and therapeutics. We work with the world’s leading drug developers to understand ...
Combining disruptive technology platforms with unparalleled genomic medicine development expertise, Precision NanoSystems’ Biopharmaceutical Services accelerates the development of lipid nanoparticle (LNP) formulations and drug products. ...
based inTarrytown, NEW YORK (USA)
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently ...
based inLouisville, KENTUCKY (USA)
Neuroscience researchers throughout the world have used Event Related Potential (ERP) and quantitative electroencephalograph (qEEG) methods to evaluate a wide range of cognitive disorders, including Alzheimer’s disease and concussion/mTBI. ...
COGNISION® is cleared by the FDA. COGNISION® is an objective biomarker system that offers clarity in a field of complexity. By facilitating an objective evaluation of patients with cognitive disorders, COGNISION® helps ...
based inDoylestown, PENNSYLVANIA (USA)
Neuropathix, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing a patented product platform of novel molecules from our proprietary socially responsible pain management therapeutics to treat patients with a ...
based inNeedham, MASSACHUSETTS (USA)
Invicro is an integral part of the REALM IDx, Inc. group, which aims to accelerate personalized medicine, discover novel therapeutic targets and develop innovative therapeutic technologies for unmet medical needs. As a global research partner to the ...
Our diverse team of experts have experience in instrument engineering, signal processing, and pharmaceutical R&D, collectively resulting in a long history designing and executing imaging and pathology studies. Our scientists have performed ...
based inDiepenbeek, BELGIUM
Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting preclinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug ...
In vitro and in vivo methods to provide a study setup that thoroughly determines safety and efficacy. ...
based inWoking, UNITED KINGDOM
IDBS is a leading provider of laboratory informatics and R&D software solutions, designed to accelerate the discovery, development, and manufacturing of therapies. Their offerings include enterprise-grade, cloud-native applications tailored for both ...
based inPrinceton, NEW JERSEY (USA)
Freyr is a leading, niche, full-service global Regulatory Solutions and Services Company supporting, Large, Medium and Small size global Life sciences companies, (Pharmaceutical | Generics | Medical Device | Biotechnology | Biosimilar | Consumer ...
After years of successful clinical research, submission of documents for Health Authority (HA) review requires a specialized skill of clear and precise clinical report writing. Such clear and precise clinical writing aids reviewers to easily ...
based inHackensack, NEW JERSEY (USA)
At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development ...
based inNorth Brunswick, NEW JERSEY (USA)
Ascendia Pharmaceutical Solutions specializes in comprehensive drug development services, providing tailored formulation and manufacturing solutions from pre-formulation stages to commercialization. With a focus on overcoming pharmaceutical ...
In the intricate landscape of biopharmaceuticals, development timing is a critical factor that can significantly impact the success or failure of a drug. Saving time can mean the difference between being first to market for a new drug class or a ...